Targeting transcription factors through an IMiD independent zinc finger domain
B. H. Liu, M. Liu, S. Radhakrishnan, C. K. Jaladanki, C. Gao, J. Tang, K. Kumari, M. L. Go, K. A. Vu Le, H.-S. Seo, K. Song, X. Tian, F. Li, J. Tan, H. Arthanari, , C. Li
This study identifies a new IMiD-independent drug targeting SALL4's ZFC4 domain, leading to significant tumor growth inhibition in vivo.
bioRxiv · Jan 3, 2024Cancer Biology